Clinical Trials Update: Aug. 30, 2010 (HealthDay)
wtorek, Sierpień 31st, 2010HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
HealthDay – MONDAY, Aug. 30 (HealthDay News) — Drinking even moderate amounts of alcohol may raise the risk for breast cancer recurrence in some women, new research indicates.
AFP – Eating a variety of fruits and vegetables may decrease the risk of some kinds of lung cancer for smokers, according to a study released Monday.
AFP – Many parents give their children too large or frequent doses of non-prescription medicines for fever, coughs and colds, putting their health at risk, according to an Australian study released Monday.
Reuters – Rates of oesophageal cancer in men have risen by 50 percent in Britain in a generation, an increase that is probably being driven in part by growing rates of obesity and poor diet, scientists said on Saturday.
AP – Even though they’ve lived with the health warnings much of their lives and doubtless seen the ill effects on friends, relatives and even themselves, about 4.5 million older Americans continue to smoke.
HealthDay – FRIDAY, Aug. 27 (HealthDay News) — Nutritional supplements are popular among Americans but people need to educate themselves and use caution when using these products to try to reduce their risk of cancer, says a University of Texas expert.
HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
HealthDay – FRIDAY, Aug. 27 (HealthDay News) — While attention-deficit hyperactivity disorder (ADHD) is a real and pervasive condition, new research suggests there is a cluster of kids and adults who successfully fake the condition either to get drugs or gain special privileges in school.
HealthDay – FRIDAY, Aug. 27 (HealthDay News) — Prescription medicines are the way that many drug addicts first get hooked, making these legal medicines the new „gateway” drugs, new study findings show.